WARSAW, Poland, Sept. 3, 2024 /PRNewswire/ — Flipster, a fast-growing crypto derivatives trading platform, has expanded its Earn Campaign to include Bitcoin (BTC) and Ether (ETH) assets, alongside its existing USDT offering. To celebrate, Flipster has announced the Earn Boost Campaign, a…
Month: September 2024
Drs. Laura L. Lawson and Eduardo C. Dias Care for Patients in Downtown Nashville NASHVILLE, Tenn., Sept. 3, 2024 /PRNewswire/ — Tennessee Oncology, a nationally recognized independent oncology practice that treats half of the state’s cancer patients across 35 clinics, announced it has…
DENVER, Sept. 3, 2024 /PRNewswire/ — Mercer Global Advisors, Inc. (“Mercer Advisors”), a national Registered Investment Adviser (RIA), today announced the acquisition of Benchmark Wealth Management, LLC (“Benchmark”). Located in Old Lyme, Connecticut, Benchmark provides holistic…
GRAND RAPIDS, Mich., Sept. 3, 2024 /PRNewswire/ — The Cancer & Hematology Centers, the largest physician-owned oncology and hematology practice in Michigan, today opened their latest site of care at 710 Kenmoor in Grand Rapids. The Cancer & Hematology Centers (CHC) Kenmoor has 12…
SAN DIEGO, Sept. 3, 2024 /PRNewswire/ — Forward Therapeutics, Inc., a next-generation biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders, today announced the appointment of Ulrich Thienel, M.D., Ph.D., as its Chief Medical Officer. Forward…
Production Begins in Charlotte, Michigan, Demonstrates Builtmore’s Agility in Adapting to the Evolving EV Market CHARLOTTE, Mich., Sept. 3, 2024 /PRNewswire/ — Builtmore Contract Manufacturing™, a go-to-market brand of The Shyft Group, Inc. (NASDAQ: SHYF), the North American leader in…
PITTSBURGH, Sept. 3, 2024 /PRNewswire/ — ATI Inc. (NYSE: ATI) announced that its Board of Directors has authorized the repurchase of up to $700 million of its outstanding common stock, which the Company currently expects will support a multi-year share repurchase program. Repurchases…
BOSTON, Sept. 3, 2024 /PRNewswire/ — Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced that…
TORONTO, Sept. 3, 2024 /PRNewswire/ – Invert Inc. (“Invert” or “the Company”), a leading carbon reduction and removal company, is proud to announce it has joined the 2024 Toronto International Film Festival (TIFF) as an official sustainability partner. This collaboration underscores…
Acquisition by OneOncology enables accelerated innovation in leading care management platform and patient reported outcomes tool, without additional cost to customers 2,000 providers and 1 million patients currently use Navigating Cancer with growth on the horizon through OneOncology…